4
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-18-040509
Options or other derivatives
- Chief Financial Officer acquired 2,480 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wells David R. · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-28 | Grant or award : show line 1 in the form Convertible Promissory Note | +0 | $10,000.00 | $0 | I | |
| 2018-06-28 | Grant or award : show line 2 in the form Warrants | +2,480 | 2,480 | I |
Loading xslF345X03/doc4.xml…